Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5
Ranjana Mitra(University of Nevada, Las Vegas), Oscar B. Goodman(Roseman University of Health Sciences)
Cited by 72
Related Papers
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2012|1.4k
Role of CYP3A5 in modulating androgen receptor signaling and its relevance to African American men with prostate cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2
CYP3A5 inhibition causes G1/S blockade and synergizes with CDK4/6 inhibitor to suppress prostate cancer cell growth: Implications in reducing health disparity
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0